MicroRNA-146a Inhibits Progression and Immune Evasion in Diffuse Large B-cell Lymphomas by Targeting Programmed Cell Death Ligand 1.
Our study indicates that miR-146a inhibits the progression of DLBCL by enhancing antitumor immunity through the targeting of PD-L1. The therapeutic potential of this miRNA in lymphoma is highly desirable.
Authors
- Kun Yang (ORCID: https://orcid.org/0000-0002-8891-5736)
- Xiang Wang (ORCID: https://orcid.org/0000-0002-0913-0501)
- Yan Li
Institutions
- Hainan General Hospital (CN)
- Hainan Medical College Hospital (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-03-30
- DOI
- https://doi.org/10.22034/iji.2025.104027.2874
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 0.00